Clinical trial
Protreat-Trial: Prophylactic Antiemetic Treatment of Opioid-induced Nausea and Vomiting (OINV) in Palliative Care: a Randomized Controlled Phase II Feasibility Trial
NCT05315999 is registered in ClinicalTrials.gov with Gerhild Becker as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Protreat-Trial: Prophylactic Antiemetic Treatment of Opioid-induced Nausea and Vomiting (OINV) in Palliative Care: a Randomized Controlled Phase II Feasibility Trial
- Lead sponsor
- Gerhild Becker
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 3, 2022
- Completion date
- December 18, 2024
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.